Odyssey Thera's Series B Round

Odyssey Thera raised a round of funding on June 22, 2002.

Odyssey Thera offers technology that measures disease-relevant pathway activity within living human cells. Rapid identification of on-target and off-pathway activities of lead compounds enables select…

Articles about Odyssey Thera's Series B Round: